Up until now all of the medications have just focused on reducing food intake. The trial was presented at the European Congress on Obesity in Venice this week, and involved 338 obese adults, half of whom were given a weekly injection of retatrutide and the other half a placebo
Always disclose your full medical history and medication list to your healthcare team
A 26-week, multicenter, double-blind trial assessed the efficacy and safety of once-daily semaglutide compared to once-daily liraglutide and placebo in patients with type 2 diabetes
This record should track bowel movements, pain severity, dietary intake, and timing relative to injection administration
Its recommended that you keep your receipts and LOMN to ensure you get reimbursed if you pay out of pocket
Retatrutide in Type 2 Diabetes: A Phase 2 Trial